Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07728331
PHASE4

Ultrasound-guided Combined Perineural and Intramuscular Dextrose Injection for Management of Refractory Bell's Palsy

Sponsor: Al-Azhar University

View on ClinicalTrials.gov

Summary

Bell's palsy (BP) is characterized by idiopathic acute weakness of the facial muscles associated with compression of the facial nerve. The present prospective study sought to evaluate the clinical efficacy of ultrasound-guided combined perineural and intramuscular dextrose injection for management of refractory Bell's palsy. The study included 30 patients with Bell's palsy with House-Brackmann scale ≥ 3 who were refractory to standard medical treatment after 3 months of disease onset. They received ultrasound-guided combined perineural and intramuscular dextrose injection. Clinical outcome was assessed using the House-Brackmann scale.

Official title: Ultrasound-guided Combined Perineural and Intramuscular Dextrose Injection for Management of Refractory Bell's Palsy A Prospective Study

Key Details

Gender

All

Age Range

Any - 18 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2025-10-10

Completion Date

2026-04-01

Last Updated

2026-07-27

Healthy Volunteers

No

Conditions

Interventions

PROCEDURE

Ultrasound-guided combined perineural and intramuscular dextrose injection.

Ultrasound-guided combined perineural and intramuscular dextrose injection.

Locations (1)

Al-Azhar University Hospital

Cairo, Egypt